Researchers at the Martin Luther University Halle-Wittenberg (MLU) have developed RNA-based active agents that appear to reliably protect plants against cucumber mosaic virus (CMV), the most common ...

In a new study, results suggest that in a preclinical model, two FDA-approved flu antivirals did not successfully treat severe H5N1 infections. Additionally, the researchers found that the route of ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid malignant tumors.

NIST's fecal RM helps standardize microbiome research to ensure accuracy, consistency, comparability, and reproducibility in the field.

Study shows maternal immune activation alters hippocampal neuron excitability in newborn rats, with implications for autism, schizophrenia, and depression.

Among other topics, conversations at the meeting focused on new methods for measuring proteins as well as opportunities for automation and AI.

Ori Biotech's Preferred Partner Network was created to help deliver solutions that speed time to the clinic and shorten development timelines.

Researchers tested computational predictions by peering into condensates using novel super-resolution microscopy methods.

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

Previous exposures to older flu strains prime the immune system to produce antibodies against bird flu (H5N1).

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...